Insiders · GENB

Frances Arnold

Director at Generate Biomedicines, Inc. (GENB)

Frances Arnold has filed 71 insider reports with the SEC since February 2021, as director at Generate Biomedicines, Inc. (GENB), director at Alphabet Inc. (GOOGL) and director at Illumina, Inc. (ILMN). In the last 12 months Frances Arnold sold $561K of stock on the open market. On September 2, 2026 Frances Arnold filed a Form 144 notice and plans to sell 32,210 GENB shares (~$521K). In the latest filing, on November 4, 2026, Frances Arnold sold 11,409 shares of Generate Biomedicines, Inc. (GENB) for $185K at an average of $16.19.

Planned sale (Form 144)

  • Frances Arnold plans to sell 32,210 GENB shares (~$521K), around Sep 2, 2026. Notice filed Sep 2, 2026.

A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.

Filings
71
Companies
3
Bought on market
None
Sold on market
$1.64M

Companies where Frances Arnold is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Generate Biomedicines, Inc. logo
GENB
Generate Biomedicines, Inc.
Director220,063$201K$9.54Nov 4, 2026
Alphabet Inc. logo
GOOGL
Alphabet Inc.
Director$1.44M$265.29Oct 2, 2026
Illumina, Inc. logo
ILMN
Illumina, Inc.
Director20,907$192.82May 23, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Frances Arnold with

Other insiders at the same companies

Questions about Frances Arnold

What is Frances Arnold's role at Generate Biomedicines, Inc.?
Frances Arnold reports to the SEC as director at Generate Biomedicines, Inc. (GENB), according to the latest filing on November 4, 2026. Frances Arnold has also filed as director at Alphabet Inc. (GOOGL) and director at Illumina, Inc. (ILMN).
How many shares does Frances Arnold own?
After the latest filing that states it, Frances Arnold directly owned 220,063 shares of Generate Biomedicines, Inc. (GENB) and 20,907 shares of Illumina, Inc. (ILMN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Frances Arnold bought or sold stock recently?
The most recent open-market sale was on October 29, 2026: sold 11,409 shares of Generate Biomedicines, Inc. (GENB) for $185K at an average of $16.19.
How do I get alerts when Frances Arnold files?
Follow Frances Arnold on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Frances Arnold filed 7 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Frances Arnold (SEC CIK 0001665419). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON